PharmExec Blog
Follow Us
RSS
Bookstore
Technology News- BioPharm News
- Shire Gains European Approval for its Gaucher Disease Treatment
- Mtech Bioprocess Scale-Up Facility to Double in Staff and Size
- ImClone Closes Plant in New Jersey, Consolidating Erbitux Manufacture
- EMA and FDA Seek Applicants for Joint GMP Inspections
- ATMI Expands Bloomington, Minnesota Manufacturing Facility
- Clinical Trials News
- CRF Health Achieves EXACT ePRO Vendor Certification for Windows Mobile Systems
- ACR Image Metrix Establishes Global Presence
- BioPharm Systems Named to the 2010 Inc. 500|5000 List of Fastest-Growing Companies in the U.S.
- CRF Health Doubles North American Headquarters
- Oracle Completes Acquisition of Phase Forward
Category Archives: Corporate Responsibility
Novartis Employees Get $250 million Payout
A Federal jury in New York ruled against Novartis in a gender discrimination lawsuit, ordering the company to pay $3.36 million in compensatory damages to 12 women and $250 million in punitive damages to 5,600 others in one of the largest gender discrimination class actions in American history. The women charged that Novartis created a [...]
Also posted in Legal, Sales Tagged Class-action Suits, Compensatory Damages, Discrimination, Harrassment, Novartis, Punitive Damages, Sales Reps Leave a comment
TB Alliance Trumpets New, Improved Drugs at World Health Assembly
Like polio and leprosy, developed countries have long since tamed tuberculosis. But even now, other parts of the world continue to struggle against the disease, with nearly all (98 percent) of TB’s 1.7 million worldwide deaths occurring in developing countries. TB’s high comorbidity with HIV infections has recently added another level of urgency to efforts [...]
Also posted in Emerging Markets, Global, R&D Tagged AIDS, Developing country, funding, HIV, Médicins Sans Frontières, neglected diseases, TB, TB Alliance, Tuberculosis, WHA, World Health Assembly Leave a comment
Is There Life After Big Pharma?
Guest blog by Pharm Exec Europe’s Jacky Law.
It’s hard to get precise figures of how many people have been taken off the payroll at pharma and biotech companies recently. According to staffing firm, Challender, Gray and Christmas, the combined industries shed 58,969 jobs in the first nine months of 2009, 15,000 more than the whole [...]
Also posted in Deals, Europe, Global, Guest Blog Tagged Big Pharma, downturn, in-licensing, Medivation, pharma. layoffs, redundancies Leave a comment
Takeda Changes Dexlansoprazole Brand Name From Kapidex to Dexilant
Takeda’s US subsidiary launched its proton pump inhibitor dexlansoprazole last February under the name Kapidex. No one thought they’d have to find a new name a year later.
But shortly after the launch, the company began getting reports of dispensing errors. Some were due to prescription misreading, others to simple, honest mistakes. The two drugs causing [...]
Also posted in FDA, Marketing, News, Safety, Strategy Tagged Casodex, chronic pain, Dexilant, dexlansoprazole, dispensing error, FDA, Kadian, Kapidex, Prostate cancer, proton pump inhibitor, Takeda 2 Comments
Johnson & Johnson Slammed Over Manufacturing Practices, Phantom Recall